Results 171 to 180 of about 5,502 (184)

Safety and Efficacy of Periprocedural Bridging With Cangrelor Versus Eptifibatide

Journal of Cardiovascular Pharmacology, 2021
: Patients with percutaneous coronary interventions undergoing procedures often require interruptions in their dual antiplatelet therapy. Periprocedural bridging is considered for patients at high thrombotic risk using intravenous cangrelor, a reversible
Allison N. Yun, A. Toyoda, Edmond J. Solomon, R. Roberts, Christine S. Ji   +4 more
semanticscholar   +1 more source

Thrombolysis Alone vs With Argatroban or Eptifibatide: A Prespecified Subgroup Analysis of the MOST Trial.

Neurology
BACKGROUND AND OBJECTIVES IV thrombolysis only (IVT-O) is the primary reperfusion therapy for most stroke patients. At least 50% of IVT-O patients remain disabled.
Akash Roy, Jordan Elm, James Ingles, Noor Sabagha, Josephine F Huang, Oladi Bentho, Tamra Ranasinghe, Christopher D Streib, Mauricio Concha, Pooja Khatri, A. Vagal, M. Wintermark, Colin P. Derdeyn, Joseph P. Broderick, Andrew D Barreto, O. Adeoye, J. Grotta   +16 more
semanticscholar   +1 more source

Acute intraprocedural thrombosis during an arterial ductal stenting successfully managed by eptifibatide

Cardiology in the Young, 2021
Acute stent thrombosis may complicate neonatal arterial duct stenting for reduced pulmonary blood flow. Thrombolytic agents recanalise the clot but may cause bleeding around the vascular sheaths and other sites. Since early thrombus is platelet mediated,
Z. Mumtaz, K. Sivakumar
semanticscholar   +1 more source

Abstract WP16: ROLE OF EPTIFIBATIDE IN POST-THROMBECTOMY STENOSIS

Stroke
Introduction: Currently, no level A evidence exists for the optimal rescue strategy for cases at high risk for re-occlusion following endovascular thrombectomy (EVT) in acute ischemic stroke.
Sivani Lingam, William Liu, Sabriya Sowers, Margaret Houghton, Laith N Maali   +4 more
semanticscholar   +1 more source

Efficacy and safety of adjunctive eptifibatide or argatroban versus control for acute ischemic stroke: A systematic review and network meta-analysis of randomized control trials

Blood
Introduction: Acute ischemic stroke is a major cause of disability and mortality, with treatment mainly limited to intravenous alteplase thrombolysis.
Teja Sureddi, Haran Srinivasan Saravanan, Noorul Hidhaya S, Gurunathan Srinivasan, Tejaswini Mariappan, Balakrishnan Kamaraj, Hrithik Dakssesh Putta Nagarajan, Nitish Thirugnanasambandam, Krishna teja Vemulaghat, Sahiti Gopu, Subash Ganesan   +10 more
semanticscholar   +1 more source

Abstract WP25: Eptifibatide in Acute Ischemic Strokes Without Large Vessel Occlusions

Stroke
Background: Platelet glycoprotein IIb/IIIa inhibitors are currently being researched for patients with acute ischemic stroke (AIS), however there is no consensus on which inhibitor or dose is both safe and effective.
Subutay B. Bozkurt, Yong-Bum Song, Joshua Haimi, S. Sahito, Muhammad Nabeel Akbar, Paul Fanous, Ibrahim Abualnadi, Abdallah O Amireh, Michael Gates, Marriam Malik, Mariah Siddiqui, Nicholas Briski, sarah Abdelmessih, Yasemin Akinci, Kiapour Nazanin, Hubashia Khan, Nancy E Gadallah, N. Tabibzadeh, Sara Strauss, A. Ghori, S. Scarpiello, Thomas Snyder   +21 more
semanticscholar   +1 more source

Efficacy outcomes and safety measures of intravenous tirofiban or eptifibatide for patients with acute ischemic stroke: a systematic review and meta-analysis of prospective studies

Journal of Thrombosis and Thrombolysis, 2021
Jingting Liu, Yihong Yang, Hongbo Liu
semanticscholar   +1 more source

PEGylated PAMAM Dendrimers as Eptifibatide Nanocarriers: An Atomistic View from Molecular Dynamics Simulations

Chemical Engineering and Science, 2022
Farideh Badalkhani-Khamseh, A. Ebrahim-Habibi, N. Hadipour, M. Behmanesh   +3 more
semanticscholar   +1 more source

Intracoronary eptifibatide with vasodilators to prevent no-reflow in diabetic STEMI with high thrombus burden. A randomized trial.

Revista Española de Cardiología, 2022
M. Hamza, I. Elgendy
semanticscholar   +1 more source

Eptifibatide as an adjuvant therapy to thrombolysis versus thrombolysis alone in stroke management: a systematic review and meta-analysis of randomized controlled trials

Journal of Thrombosis and Thrombolysis
L. Carretta, O. Gonçalves, Luiz Guilherme Silva Almeida, S. Souza, C. Fukunaga, F. Bezerra, Luiz Felipe Simões Antunes Nery Dos Santos, Pedro Rodrigues Teixeira, Ítalo Barros Andrade, Fabrício Salazar Fiorio Marques, Y. Silva, G. Noleto   +11 more
semanticscholar   +1 more source